%PDF-1.4
%
64 0 obj
<>
endobj
61 0 obj
<>
endobj
121 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2003-07-08T18:59:42Z
2024-03-29T03:59:33-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-29T03:59:33-07:00
application/pdf
Heather
2002-579.aug
uuid:edffcdaf-1dd1-11b2-0a00-0b09278d5b00
uuid:edffcdb1-1dd1-11b2-0a00-1e0000000000
endstream
endobj
50 0 obj
<>
endobj
51 0 obj
<>
endobj
65 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 34 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 36 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 38 0 R/Type/Page>>
endobj
12 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 40 0 R/Type/Page>>
endobj
25 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 42 0 R/Type/Page>>
endobj
28 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 44 0 R/Type/Page>>
endobj
143 0 obj
[147 0 R]
endobj
144 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 74.4 714.5293 Tm
(self-peptides from CD34\(\320\) peripheral blood mononuclear cells of)Tj
0 -1.25 TD
[(dif)17.7 (ferent tumor patients \(plasmacytoma, chronic myeloid)]TJ
T*
(leukemia\). Blood 2000;95:2890-6.)Tj
-2.175 -1.25 Td
[(28.)-875.1 (Barnathan ES, Raghunath PN, )17.7 (T)69.9 (omaszewski JE, Ganz )17.7 (T)74 (,)-0.1 ( Cines DB,)]TJ
2.175 -1.25 Td
[(Higazi )54.8 (A-R. Immunohistochemical localization of defensin in)]TJ
T*
[(human coronary vessels. )54.8 (Am J Pathol 1997;150:1009-20.)]TJ
-2.175 -1.25 Td
[(29.)-875.1 (Zaslof)17.7 (f M. )54.8 (Antimicrobial peptides of multicellular or)17.7 (ganisms.)]TJ
2.175 -1.25 Td
(Nature 2002;415:389-95.)Tj
-2.175 -1.25 Td
[(30.)-875.1 (T)69.9 (ani K, Murphy )17.7 (WJ, Chertov O, et al. Defensins act as potent )]TJ
2.175 -1.25 Td
(adjuvants that promote cellular and humoral immune responses in)Tj
T*
(mice to a lymphoma idiotype and carrier antigens. Int Immunol)Tj
0 Tc 0 Tw T*
(2000;12:691-700.)Tj
-0.00011 Tc 0.02499 Tw 30.825 13.75 Td
[(31.)-875.1 (Y)99.8 (ang D, Chen Q, Chertov O, Oppenheim JJ. Human neutrophil)]TJ
2.175 -1.25 Td
[(defensins selectively chemoattract naive )17.7 (T)-257.1 (and immature dendritic)]TJ
T*
(cells. J Leukoc Biol 2000;68:9-14.)Tj
-2.175 -1.25 Td
[(32.)-875.1 (Panyutich )54.8 (A, Ganz )17.7 (T)74 (.)-0.1 ( )54.8 (Activated alpha 2-macroglobulin is a )]TJ
2.175 -1.25 Td
[(principal defensin-binding protein. )54.8 (Am J Respir Cell Mol Biol)]TJ
0 Tc 0 Tw T*
(1991;5:101-6.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(33.)-875.1 (Higazi )54.8 (AA, Nassar )17.7 (T)74 (, Ganz )17.7 (T)74 (, et al. )17.7 (The alpha-defensins stimulate)]TJ
2.175 -1.25 Td
(proteoglycan-dependent catabolism of low-density lipoprotein by)Tj
T*
(vascular cells: a new class of inflammatory apolipoprotein and a)Tj
T*
(possible contributor to atherogenesis. Blood 2000;96:1393-8.)Tj
ET
0 0 0 1 K
54 54 m
558 54 l
S
BT
/T1_1 1 Tf
8 0 0 8 424.3613 35.9844 Tm
(The Journal of Rheumatology 2003; 30:8)Tj
0 Tc 0 Tw -46.2952 -0.0313 Td
(1724)Tj
ET
0 0 0 0 k
/GS0 gs
109.25 59.1 396.47 -10.84 re
f*
0.5 w
109.25 59.1 396.47 -10.84 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_2 8 Tf
117.48 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology Copyrig\
ht \251 2003. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_3 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
44 0 obj
<>stream
8;Z\sCCZ"?%#!gC([Q9FdjGM+1&>B=o4]nAZ(7116HH?]o00;Zd:[?S^-WE5k\'a.
6J86V'%h(6KF3hE_cWAD;\+l"mti0M\ntZqTN7@9>4IEk0=UF'&9#%#3VqXcs6A@K
?5,O0--i5\7@:Vr?n0rd+$9#LHt-f\Y`,4sPF]Q``'MFSa4Q`[2@/_)mk.l@I9bRX
kVF%O=\F:.1JR8GA(>fj#U+j463n`f&4-Z5$heika3-b@C2^AaSI!9L%RE<~>
endstream
endobj
48 0 obj
[/Indexed/DeviceRGB 255 47 0 R]
endobj
47 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
71 0 obj
<>
endobj
67 0 obj
<>
endobj
108 0 obj
<>
endobj
126 0 obj
<>
endobj
68 0 obj
<>
endobj
101 0 obj
<>stream
HUiPSY~/%(C6Ie1"2
Z-*(!H$MHQ@F6nŶqQKi{lkƙҗgjLSι߹8fpٿB@n4"^>vh'^r3pZ氅͵E[Wl¹WIGoKeVdunnnn;ĉdaL&
G
xe@$M''#h>P+%$TSC<&GDDɧx<_aX*Kw"yBS$%R"F$~d_1dfi-'Oc|ۀaͰ
0y11ۊaqsOiF?{Iyy3 ${+{t'7ZT㋧-,:,]d_tzYFa+'RkK`66O(jvmro9j{xL/e9 Ĩ)ˋԕ 9